ArticleCureus2025
Idiopathic Parkinson's Disease Unmasked by Valproate-Induced Parkinsonism in a Patient With Vestibular Migraine.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of idiopathic Parkinson's disease (PD) in a patient with vestibular migraine (VM), initially suspected to have valproate-induced Parkinsonism. Valproate was started at 200 mg/day and titrated to 1,000 mg/day over four months for headache control. Although valproate provided effective headache relief, neurological symptoms, including hand tremor, shoulder stiffness, drooling, and adiadochokinesis, emerged and persisted despite discontinuation of the drug. Subsequent imaging studies, including dopamine transporter-single-photon emission computed tomography and 123I-meta-iodobenzylguanidine myocardial scintigraphy, confirmed the diagnosis of PD by the neurology department. This case highlights the need for careful monitoring of neurological signs during and after valproate therapy in VM patients, as latent PD may be unmasked.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.